Ferozsons Laboratories Statistics

Total Valuation

Ferozsons Laboratories has a market cap or net worth of PKR 14.57 billion. The enterprise value is 17.08 billion.

Market Cap	14.57B
Enterprise Value	17.08B

Important Dates

The next estimated earnings date is Monday, February 17, 2025.

Earnings Date	Feb 17, 2025
Ex-Dividend Date	Oct 18, 2024

Share Statistics

Ferozsons Laboratories has 43.47 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class	n/a
Shares Outstanding	43.47M
Shares Change (YoY)	-0.05%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	7.94%
Float	10.77M

Valuation Ratios

The trailing PE ratio is 22.74.

PE Ratio	22.74
Forward PE	n/a
PS Ratio	0.91
PB Ratio	1.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.96, with an EV/FCF ratio of -15.31.

EV / Earnings	26.67
EV / Sales	1.07
EV / EBITDA	7.96
EV / EBIT	10.98
EV / FCF	-15.31

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.42.

Current Ratio	1.47
Quick Ratio	0.78
Debt / Equity	0.42
Debt / EBITDA	2.33
Debt / FCF	-4.49
Interest Coverage	2.16

Financial Efficiency

Return on equity (ROE) is 6.91% and return on invested capital (ROIC) is 6.75%.

Return on Equity (ROE)	6.91%
Return on Assets (ROA)	4.65%
Return on Capital (ROIC)	6.75%
Revenue Per Employee	8.42M
Profits Per Employee	337,786
Employee Count	1,896
Asset Turnover	0.76
Inventory Turnover	1.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+64.34%
50-Day Moving Average	296.37
200-Day Moving Average	254.35
Relative Strength Index (RSI)	67.96
Average Volume (20 Days)	349,788

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ferozsons Laboratories had revenue of PKR 15.96 billion and earned 640.44 million in profits. Earnings per share was 14.73.

Revenue	15.96B
Gross Profit	6.57B
Operating Income	1.56B
Pretax Income	1.03B
Net Income	640.44M
EBITDA	2.15B
EBIT	1.56B
Earnings Per Share (EPS)	14.73

Full Income Statement

Balance Sheet

The company has 3.10 billion in cash and 5.01 billion in debt, giving a net cash position of -1.90 billion or -43.77 per share.

Cash & Cash Equivalents	3.10B
Total Debt	5.01B
Net Cash	-1.90B
Net Cash Per Share	-43.77
Equity (Book Value)	12.06B
Book Value Per Share	263.38
Working Capital	3.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -529.96 million and capital expenditures -585.63 million, giving a free cash flow of -1.12 billion.

Operating Cash Flow	-529.96M
Capital Expenditures	-585.63M
Free Cash Flow	-1.12B
FCF Per Share	-25.66

Full Cash Flow Statement

Margins

Gross margin is 41.18%, with operating and profit margins of 9.75% and 4.01%.

Gross Margin	41.18%
Operating Margin	9.75%
Pretax Margin	6.48%
Profit Margin	4.01%
EBITDA Margin	13.46%
EBIT Margin	9.75%
FCF Margin	-6.99%

Dividends & Yields

This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.93%.

Dividend Per Share	3.00
Dividend Yield	0.93%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.13%
Buyback Yield	0.05%
Shareholder Yield	0.98%
Earnings Yield	4.40%
FCF Yield	-7.66%

Dividend Details

Stock Splits

The last stock split was on September 21, 2022. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 21, 2022
Split Type	Forward
Split Ratio	1.2

Scores

Ferozsons Laboratories has an Altman Z-Score of 1.99. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.99
Piotroski F-Score	n/a